Cargando…

Identification and validation of heterotypic cell-in-cell structure as an adverse prognostic predictor for young patients of resectable pancreatic ductal adenocarcinoma

Detalles Bibliográficos
Autores principales: Huang, Hongyan, He, Meifang, Zhang, Yanbin, Zhang, Bo, Niu, Zubiao, Zheng, You, Li, Wen, Cui, Peilin, Wang, Xiaoning, Sun, Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7576137/
https://www.ncbi.nlm.nih.gov/pubmed/33082315
http://dx.doi.org/10.1038/s41392-020-00346-w
_version_ 1783597955154968576
author Huang, Hongyan
He, Meifang
Zhang, Yanbin
Zhang, Bo
Niu, Zubiao
Zheng, You
Li, Wen
Cui, Peilin
Wang, Xiaoning
Sun, Qiang
author_facet Huang, Hongyan
He, Meifang
Zhang, Yanbin
Zhang, Bo
Niu, Zubiao
Zheng, You
Li, Wen
Cui, Peilin
Wang, Xiaoning
Sun, Qiang
author_sort Huang, Hongyan
collection PubMed
description
format Online
Article
Text
id pubmed-7576137
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-75761372020-10-23 Identification and validation of heterotypic cell-in-cell structure as an adverse prognostic predictor for young patients of resectable pancreatic ductal adenocarcinoma Huang, Hongyan He, Meifang Zhang, Yanbin Zhang, Bo Niu, Zubiao Zheng, You Li, Wen Cui, Peilin Wang, Xiaoning Sun, Qiang Signal Transduct Target Ther Letter Nature Publishing Group UK 2020-10-20 /pmc/articles/PMC7576137/ /pubmed/33082315 http://dx.doi.org/10.1038/s41392-020-00346-w Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Letter
Huang, Hongyan
He, Meifang
Zhang, Yanbin
Zhang, Bo
Niu, Zubiao
Zheng, You
Li, Wen
Cui, Peilin
Wang, Xiaoning
Sun, Qiang
Identification and validation of heterotypic cell-in-cell structure as an adverse prognostic predictor for young patients of resectable pancreatic ductal adenocarcinoma
title Identification and validation of heterotypic cell-in-cell structure as an adverse prognostic predictor for young patients of resectable pancreatic ductal adenocarcinoma
title_full Identification and validation of heterotypic cell-in-cell structure as an adverse prognostic predictor for young patients of resectable pancreatic ductal adenocarcinoma
title_fullStr Identification and validation of heterotypic cell-in-cell structure as an adverse prognostic predictor for young patients of resectable pancreatic ductal adenocarcinoma
title_full_unstemmed Identification and validation of heterotypic cell-in-cell structure as an adverse prognostic predictor for young patients of resectable pancreatic ductal adenocarcinoma
title_short Identification and validation of heterotypic cell-in-cell structure as an adverse prognostic predictor for young patients of resectable pancreatic ductal adenocarcinoma
title_sort identification and validation of heterotypic cell-in-cell structure as an adverse prognostic predictor for young patients of resectable pancreatic ductal adenocarcinoma
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7576137/
https://www.ncbi.nlm.nih.gov/pubmed/33082315
http://dx.doi.org/10.1038/s41392-020-00346-w
work_keys_str_mv AT huanghongyan identificationandvalidationofheterotypiccellincellstructureasanadverseprognosticpredictorforyoungpatientsofresectablepancreaticductaladenocarcinoma
AT hemeifang identificationandvalidationofheterotypiccellincellstructureasanadverseprognosticpredictorforyoungpatientsofresectablepancreaticductaladenocarcinoma
AT zhangyanbin identificationandvalidationofheterotypiccellincellstructureasanadverseprognosticpredictorforyoungpatientsofresectablepancreaticductaladenocarcinoma
AT zhangbo identificationandvalidationofheterotypiccellincellstructureasanadverseprognosticpredictorforyoungpatientsofresectablepancreaticductaladenocarcinoma
AT niuzubiao identificationandvalidationofheterotypiccellincellstructureasanadverseprognosticpredictorforyoungpatientsofresectablepancreaticductaladenocarcinoma
AT zhengyou identificationandvalidationofheterotypiccellincellstructureasanadverseprognosticpredictorforyoungpatientsofresectablepancreaticductaladenocarcinoma
AT liwen identificationandvalidationofheterotypiccellincellstructureasanadverseprognosticpredictorforyoungpatientsofresectablepancreaticductaladenocarcinoma
AT cuipeilin identificationandvalidationofheterotypiccellincellstructureasanadverseprognosticpredictorforyoungpatientsofresectablepancreaticductaladenocarcinoma
AT wangxiaoning identificationandvalidationofheterotypiccellincellstructureasanadverseprognosticpredictorforyoungpatientsofresectablepancreaticductaladenocarcinoma
AT sunqiang identificationandvalidationofheterotypiccellincellstructureasanadverseprognosticpredictorforyoungpatientsofresectablepancreaticductaladenocarcinoma